KR0150634B1 - 5-치환된 오르니틴 유도체 및 이를 함유하는 약제학적 조성물 - Google Patents

5-치환된 오르니틴 유도체 및 이를 함유하는 약제학적 조성물 Download PDF

Info

Publication number
KR0150634B1
KR0150634B1 KR1019890001267A KR890001267A KR0150634B1 KR 0150634 B1 KR0150634 B1 KR 0150634B1 KR 1019890001267 A KR1019890001267 A KR 1019890001267A KR 890001267 A KR890001267 A KR 890001267A KR 0150634 B1 KR0150634 B1 KR 0150634B1
Authority
KR
South Korea
Prior art keywords
acid
solution
ornithine
mixture
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019890001267A
Other languages
English (en)
Korean (ko)
Other versions
KR890012942A (ko
Inventor
이. 게르하트 프리쯔
제이. 사일러 니콜라우스
Original Assignee
개리 디. 스트리트
메렐 다우 파마슈티칼스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 개리 디. 스트리트, 메렐 다우 파마슈티칼스 인코포레이티드 filed Critical 개리 디. 스트리트
Publication of KR890012942A publication Critical patent/KR890012942A/ko
Application granted granted Critical
Publication of KR0150634B1 publication Critical patent/KR0150634B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
KR1019890001267A 1988-02-05 1989-02-03 5-치환된 오르니틴 유도체 및 이를 함유하는 약제학적 조성물 Expired - Fee Related KR0150634B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88400275,9 1988-02-05
EP88400275,9 1988-02-05
EP88400275A EP0326766B1 (en) 1988-02-05 1988-02-05 5-substituted ornithine derivatives

Publications (2)

Publication Number Publication Date
KR890012942A KR890012942A (ko) 1989-09-20
KR0150634B1 true KR0150634B1 (ko) 1998-10-15

Family

ID=8200349

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890001267A Expired - Fee Related KR0150634B1 (ko) 1988-02-05 1989-02-03 5-치환된 오르니틴 유도체 및 이를 함유하는 약제학적 조성물

Country Status (22)

Country Link
US (1) US4902719A (enExample)
EP (1) EP0326766B1 (enExample)
JP (1) JP2816431B2 (enExample)
KR (1) KR0150634B1 (enExample)
CN (1) CN1027891C (enExample)
AR (1) AR244657A1 (enExample)
AT (1) ATE77367T1 (enExample)
AU (1) AU612229B2 (enExample)
CA (1) CA1311767C (enExample)
DE (1) DE3872213T2 (enExample)
DK (1) DK172113B1 (enExample)
ES (1) ES2041815T3 (enExample)
FI (1) FI90530C (enExample)
GR (1) GR3005551T3 (enExample)
HU (1) HU204770B (enExample)
IE (1) IE63162B1 (enExample)
IL (1) IL89145A (enExample)
NO (1) NO176242C (enExample)
NZ (1) NZ227783A (enExample)
PH (1) PH26422A (enExample)
PT (1) PT89637B (enExample)
ZA (1) ZA89833B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016035A1 (en) * 1990-04-26 1991-10-31 The Procter & Gamble Company Chelator compositions comprising alpha-diamine compounds
EP0609630A1 (en) * 1993-02-05 1994-08-10 Merrell Dow Pharmaceuticals Inc. Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of Alzheimer's disease
US5677350A (en) * 1995-06-07 1997-10-14 Wisconsin Alumni Research Foundation Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes
GB9617822D0 (en) * 1996-08-27 1996-10-09 Lilly Industries Ltd Pharmaceutical compounds
US6043218A (en) 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
US6566330B1 (en) 1996-10-22 2003-05-20 Medical University Of South Carolina Foundation Research Development Positively charged non-natural amino acids, methods of making and using thereof in peptides
US7166234B1 (en) * 2000-10-26 2007-01-23 Integrated Biomedical Technology, Inc. Dialdehyde assay
US6911544B2 (en) * 2002-10-23 2005-06-28 Pfizer Inc. Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine
EP3062175B1 (en) 2013-10-21 2018-09-05 Fuji Electric Co., Ltd. Control system design assist device, control system design assist program, control system design assist method, operation change amount calculation device, and control device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1091661A (en) * 1977-07-11 1980-12-16 Philippe Bey .alpha.-HALOMETHYL DERIVATIVES OF .alpha.-AMINO ACIDS
US4326071A (en) * 1977-09-28 1982-04-20 Merrell Toraude Et Compagnie Halomethyl derivatives of gamma-aminobutyric acid and related compounds
AU544990B2 (en) * 1980-06-16 1985-06-27 Merrell Pharmaceuticals Inc. Antiprotozal composition containing amino compounds
US4668703A (en) * 1983-07-07 1987-05-26 Syntex (U.S.A.) Inc. γ-allenyl-γ-aminobutyric acids

Also Published As

Publication number Publication date
AR244657A1 (es) 1993-11-30
IL89145A (en) 1993-08-18
US4902719A (en) 1990-02-20
DK51589A (da) 1989-08-06
ZA89833B (en) 1989-10-25
CN1037142A (zh) 1989-11-15
EP0326766A1 (en) 1989-08-09
FI890477A0 (fi) 1989-02-01
FI890477L (fi) 1989-08-06
DK172113B1 (da) 1997-11-10
FI90530B (fi) 1993-11-15
NO176242C (no) 1995-03-01
HUT49320A (en) 1989-09-28
JP2816431B2 (ja) 1998-10-27
JPH021435A (ja) 1990-01-05
GR3005551T3 (enExample) 1993-06-07
EP0326766B1 (en) 1992-06-17
CN1027891C (zh) 1995-03-15
NO890455L (no) 1989-08-07
PT89637A (pt) 1989-10-04
IE63162B1 (en) 1995-03-22
ATE77367T1 (de) 1992-07-15
FI90530C (fi) 1994-02-25
NO176242B (no) 1994-11-21
KR890012942A (ko) 1989-09-20
PH26422A (en) 1992-07-15
DE3872213D1 (de) 1992-07-23
CA1311767C (en) 1992-12-22
PT89637B (pt) 1994-02-28
IE890356L (en) 1989-08-05
IL89145A0 (en) 1989-09-10
HU204770B (en) 1992-02-28
DK51589D0 (da) 1989-02-03
ES2041815T3 (es) 1993-12-01
AU2951589A (en) 1989-08-10
NZ227783A (en) 1990-12-21
DE3872213T2 (de) 1993-01-28
NO890455D0 (no) 1989-02-03
AU612229B2 (en) 1991-07-04

Similar Documents

Publication Publication Date Title
JP5819954B2 (ja) 抗炎症剤、免疫調節剤及び抗増殖剤としての化合物の新規カルシウム塩
US3784697A (en) Pharmaceutical composition containing phenoxyalkane-carboxylic acids,salts and esters thereof
DE69707865T2 (de) Biphenylsulfonamid matrix metalloproteinase inhibitoren
JPH0472839B2 (enExample)
Kolb et al. Synthesis and evaluation of mono-, di-, and trifluoroethenyl-GABA derivatives as GABA-T inhibitors
KR0150634B1 (ko) 5-치환된 오르니틴 유도체 및 이를 함유하는 약제학적 조성물
EP0147475B1 (en) Aminocyclohexanol derivatives having an expectorant activity, process for their preparation and pharmaceutical compositions containing them
PL84190B1 (en) 3-aroyl-alkenyleneimines[us3835149a]
JPS6251A (ja) シス，エンド−２−アザビシクロ〔３．３．０〕オクタン−３−カルボン酸誘導体およびその製法
NO161853B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamidforbindelser.
KR0181945B1 (ko) N,n'-비스(알콕시알킬)-피리딘-2,4-디카복실산 디아미드, 이의 제조방법 및 이를 함유하는 약제학적 조성물
JPS6399057A (ja) グリシン誘導体
JPS5892646A (ja) ベンジリデン誘導体
EP0155524A1 (en) -Omega-aryl-alkylthienyl compounds, process for their preparation and pharmaceutical products containing these compounds
FR2572405A1 (fr) Nouveaux derives de la phenethylaminoalcoyle-6 furo-(3,4-c)-pyridine et leur procede de preparation
JP2003533506A5 (ja) システインカテプシン阻害剤としてのｎ-置換ペプチジルニトリル
FR2571965A1 (fr) Medicaments a base de nouveaux derives de la 4 h-dioxino-(4,5-c)-pyridine.
NZ223805A (en) Preparation of optically active oxo-isoindolinyl derivatives, and pharmaceutical compositions containing them
JPH0812656A (ja) ヘキサヒドロアゼピノンおよびヘキサヒドロアゼピノールの製造方法
JPH0445509B2 (enExample)
FR2670208A1 (fr) Derives de phenyl-1 dihydro 1-4 arylalcoylamino-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique.
JPS61200954A (ja) ジフエニルアゾメチン類の製造方法
JPS61140549A (ja) １０，１１‐ジヒドロ‐５Ｈ‐ジベンゾ〔ａ，ｄ〕シクロヘプタジエン誘導体、その製法及び該化合物を含有する薬剤
EP0091078A1 (en) A process for the preparation of derivatives of 2-diethylamino-1-methyl ethyl cis-1-hydroxy-(bicyclohexyl)-2-carboxylate
JPH0327357A (ja) 新規環状アントラニル酸誘導体及びその製造法

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20040609

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20050617

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20050617

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000